A lawsuit filed in the US district court in San Francisco has accused three pharmaceutical firms -Boots Co of UK, BASF AG of Germany and its US subsidiary Knoll Pharmaceuticals -of covering up a report questioning the effectiveness of a thyroid drug. The lawsuit alleges that the drug companies concealed a seven-year-long study that concluded that their thyroid drug, Synthroid, was no better than cheaper generic brands at treating people suffering from hypothyroidism, a condition caused by an underactive thyroid gland. Martin Wakeling, a Boots spokes- person, dismissed the allegations as "totally fanciful".
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.